Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.

BACKGROUND Circulating trans fatty acids (TFAs), which cannot be synthesized by humans, are linked to adverse health outcomes. Although TFAs are obtained from diet, little is known about subsequent influences (e.g., relating to incorporation, metabolism, or intercompetition with other fatty acids) that could alter circulating concentrations and possibly modulate or mediate impacts on health. OBJECTIVE The objective was to elucidate novel biologic pathways that may influence circulating TFAs by evaluating associations between common genetic variation and TFA biomarkers. DESIGN We performed meta-analyses using 7 cohorts of European-ancestry participants (n = 8013) having measured genome-wide variation in single-nucleotide polymorphisms (SNPs) and circulating TFA biomarkers (erythrocyte or plasma phospholipids), including trans-16:1n-7, total trans-18:1, trans/cis-18:2, cis/trans-18:2, and trans/trans-18:2. We further evaluated SNPs with genome-wide significant associations among African Americans (n = 1082), Chinese Americans (n = 669), and Hispanic Americans (n = 657) from 2 of these cohorts. RESULTS Among European-ancestry participants, 31 SNPs in or near the fatty acid desaturase (FADS) 1 and 2 cluster were associated with cis/trans-18:2; a top hit was rs174548 (β = 0.0035, P = 4.90 × 10(-15)), an SNP previously associated with circulating n-3 and n-6 polyunsaturated fatty acid concentrations. No significant association was identified for other TFAs. rs174548 in FADS1/2 was also associated with cis/trans-18:2 in Hispanic Americans (β = 0.0053, P = 1.05 × 10(-6)) and Chinese Americans (β = 0.0028, P = 0.002) but not African Americans (β = 0.0009, P = 0.34); however, in African Americans, fine mapping identified a top hit in FADS2 associated with cis/trans-18:2 (rs174579: β = 0.0118, P = 4.05 × 10(-5)). The association between rs174548 and cis/trans-18:2 remained significant after further adjustment for individual circulating n-3 and n-6 fatty acids, except arachidonic acid. After adjustment for arachidonic acid concentrations, the association between rs174548 and cis/trans-18:2 was nearly eliminated in European-ancestry participants (β-coefficient reduced by 86%), with similar reductions in Hispanic Americans and Chinese Americans. CONCLUSIONS Our findings provide novel evidence for genetic regulation of cis/trans-18:2 by the FADS1/2 cluster and suggest that this regulation may be influenced/mediated by concentrations of arachidonic acid, an n-6 polyunsaturated fat.

[1]  P. Barberger‐Gateau,et al.  Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. , 2008, The American journal of clinical nutrition.

[2]  J. H. Lee,et al.  FADS gene polymorphisms in Koreans: association with ω6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease. , 2011, Atherosclerosis.

[3]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[4]  A. Lorenzini,et al.  Dual influence of aging and vitamin B6 deficiency on delta-6-desaturation of essential fatty acids in rat liver microsomes. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[5]  C. Haest Distribution and Movement of Membrane Lipids , 2003 .

[6]  J. Bertrandt,et al.  Influence of vitamin B6 supplementation on polyunsaturated fatty acids concentration in serum and liver of rats fed a diet restricted in protein. , 2004, Die Nahrung.

[7]  C. Serhan,et al.  Novel anti-inflammatory--pro-resolving mediators and their receptors. , 2011, Current topics in medicinal chemistry.

[8]  T. Raghunathan,et al.  Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. , 1995, JAMA.

[9]  P. Rzehak,et al.  Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes , 2008, British Journal of Nutrition.

[10]  Michael Müller,et al.  Dietary n-3 and n-6 polyunsaturated fatty acid intake interacts with FADS1 genetic variation to affect total and HDL-cholesterol concentrations in the Doetinchem Cohort Study. , 2010, The American journal of clinical nutrition.

[11]  E. Shahar,et al.  Docosahexaenoic acid and smoking-related chronic obstructive pulmonary disease. The Atherosclerosis Risk in Communities Study Investigators. , 1999, American journal of respiratory and critical care medicine.

[12]  S. Innis,et al.  Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. , 2007, The Journal of nutrition.

[13]  D. Mozaffarian,et al.  Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study. , 2010, The American journal of clinical nutrition.

[14]  D. Mozaffarian,et al.  Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. , 2008, The American journal of clinical nutrition.

[15]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[16]  Luigi Ferrucci,et al.  Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study , 2009, PLoS genetics.

[17]  Thomas Illig,et al.  FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. , 2008, The American journal of clinical nutrition.

[18]  M. Zeegers,et al.  FADS1 FADS2 gene variants modify the association between fish intake and the docosahexaenoic acid proportions in human milk. , 2010, The American journal of clinical nutrition.

[19]  M. Kodama,et al.  A case-control pilot study on n-3 polyunsaturated fatty acid as a negative risk factor for myocardial infarction. , 2005, International heart journal.

[20]  L. Lind,et al.  Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men , 2006 .

[21]  F. Hu,et al.  Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. , 2007, The American journal of clinical nutrition.

[22]  Christian Gieger,et al.  New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk , 2010, Nature Genetics.

[23]  Xiaoyi Gao Multiple testing corrections for imputed SNPs , 2011, Genetic epidemiology.

[24]  H. Hattori,et al.  Thr-encoding allele homozygosity at codon 54 of FABP 2 gene may be associated with impaired delta 6 desatruase activity and reduced plasma arachidonic acid in obese children. , 2006, Journal of atherosclerosis and thrombosis.

[25]  Song-Mei Liu,et al.  FADS Gene Polymorphisms Confer the Risk of Coronary Artery Disease in a Chinese Han Population through the Altered Desaturase Activities: Based on High-Resolution Melting Analysis , 2013, PloS one.

[26]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[27]  S. Wootton,et al.  Conversion of α-linolenic acid to palmitic, palmitoleic, stearic and oleic acids in men and women , 2003 .

[28]  D. Mozaffarian,et al.  trans fatty acids and systemic inflammation in heart failure. , 2004, The American journal of clinical nutrition.

[29]  R. Mensink,et al.  Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. , 2006, The American journal of clinical nutrition.

[30]  T. Lakka,et al.  Fish Oil–Derived Fatty Acids, Docosahexaenoic Acid and Docosapentaenoic Acid, and the Risk of Acute Coronary Events: The Kuopio Ischaemic Heart Disease Risk Factor Study , 2000, Circulation.

[31]  D. Grobbee,et al.  Fish Oil and Glycemic Control in Diabetes: A meta-analysis , 1998, Diabetes Care.

[32]  P. Barberger‐Gateau,et al.  Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. , 2008, The American journal of clinical nutrition.

[33]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[34]  M. Fornage,et al.  Genetic Loci Associated with Plasma Phospholipid n-3 Fatty Acids: A Meta-Analysis of Genome-Wide Association Studies from the CHARGE Consortium , 2011, PLoS genetics.

[35]  D. Mozaffarian,et al.  Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes , 2009, Nature Reviews Endocrinology.

[36]  L. Palmer,et al.  Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. , 2006, Human molecular genetics.

[37]  D. Siscovick,et al.  Familial aggregation of red blood cell membrane fatty acid composition: the Kibbutzim Family Study. , 2008, Metabolism: clinical and experimental.

[38]  J. Lampe,et al.  Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. , 2007, The American journal of clinical nutrition.

[39]  W. Lands Metabolism of glycerolipides; a comparison of lecithin and triglyceride synthesis. , 1958, The Journal of biological chemistry.

[40]  T. Raghunathan,et al.  Cell Membrane Trans-Fatty Acids and the Risk of Primary Cardiac Arrest , 2002, Circulation.

[41]  Christian Gieger,et al.  Genome-wide association analysis identifies multiple loci related to resting heart rate. , 2010, Human molecular genetics.

[42]  R. Lemaitre,et al.  Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. , 2006, The American journal of clinical nutrition.

[43]  Charles E. McCulloch,et al.  Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models , 2005 .

[44]  W. Harris,et al.  Why do omega-3 fatty acids lower serum triglycerides? , 2006, Current opinion in lipidology.

[45]  I. Ruczinski,et al.  Adaptive Evolution of the FADS Gene Cluster within Africa , 2012, PloS one.

[46]  A. Hofman,et al.  Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. , 2003, The American journal of clinical nutrition.

[47]  M. Province,et al.  Avoiding the high Bonferroni penalty in genome‐wide association studies , 2009, Genetic epidemiology.

[48]  Donna K Arnett,et al.  A genome-wide association study of inflammatory biomarker changes in response to fenofibrate treatment in the Genetics of Lipid Lowering Drug and Diet Network , 2012, Pharmacogenetics and genomics.

[49]  C. Langefeld,et al.  Differences in arachidonic acid levels and fatty acid desaturase (FADS) gene variants in African Americans and European Americans with diabetes or the metabolic syndrome , 2011, British Journal of Nutrition.

[50]  W. Guan,et al.  Genome-Wide Association Study of Plasma N6 Polyunsaturated Fatty Acids Within the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium , 2014, Circulation. Cardiovascular genetics.

[51]  Thomas Illig,et al.  SNPs of the FADS Gene Cluster are Associated with Polyunsaturated Fatty Acids in a Cohort of Patients with Cardiovascular Disease , 2008, Lipids.

[52]  A. Folsom,et al.  Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2008, American heart journal.

[53]  Jon W. Huss,et al.  BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources , 2009, Genome Biology.

[54]  S. Sharp,et al.  Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. , 2010, The American journal of clinical nutrition.

[55]  Manabu T. Nakamura,et al.  Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element. , 2003, Journal of lipid research.

[56]  E. Rimm,et al.  Fatty Acid Desaturase Gene Variants, Cardiovascular Risk Factors, and Myocardial Infarction in the Costa Rica Study , 2012, Front. Gene..

[57]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[58]  J. Boer,et al.  Markers of Endogenous Desaturase Activity and Risk of Coronary Heart Disease in the CAREMA Cohort Study , 2012, PloS one.

[59]  D. Mozaffarian,et al.  Dietary intake of trans fatty acids and systemic inflammation in women. , 2004, The American journal of clinical nutrition.

[60]  A. Sala-Vila,et al.  Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia. , 2010, The American journal of clinical nutrition.

[61]  P. Amouyel,et al.  Single nucleotide polymorphisms in the FADS gene cluster are associated with delta-5 and delta-6 desaturase activities estimated by serum fatty acid ratios[S] , 2010, Journal of Lipid Research.

[62]  D. Mozaffarian,et al.  Plasma Phospholipid Trans Fatty Acids, Fatal Ischemic Heart Disease, and Sudden Cardiac Death in Older Adults: The Cardiovascular Health Study , 2006, Circulation.

[63]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[64]  G. Abecasis,et al.  MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes , 2010, Genetic epidemiology.

[65]  I. Ruczinski,et al.  The impact of FADS genetic variants on ω6 polyunsaturated fatty acid metabolism in African Americans , 2011, BMC Genetics.

[66]  K. Lunetta,et al.  Methods in Genetics and Clinical Interpretation Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Design of Prospective Meta-Analyses of Genome-Wide Association Studies From 5 Cohorts , 2010 .

[67]  R. Barr,et al.  Frequency and type of seafood consumed influence plasma (n-3) fatty acid concentrations. , 2008, The Journal of nutrition.

[68]  P. Donnelly,et al.  A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.

[69]  Edward A Dennis,et al.  The human plasma lipidome. , 2011, The New England journal of medicine.

[70]  Thomas W. Mühleisen,et al.  Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease , 2011, Nature Genetics.

[71]  S. Innis,et al.  Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. , 2008, The Journal of nutrition.

[72]  B. Hammock,et al.  Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer. , 2014, Progress in lipid research.

[73]  Heiner Boeing,et al.  Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study , 2010, British Journal of Nutrition.

[74]  M. Orho-Melander,et al.  Intake levels of dietary long-chain PUFAs modify the association between genetic variation in FADS and LDL-C[S] , 2012, Journal of Lipid Research.

[75]  M. Stephens,et al.  Imputation-Based Analysis of Association Studies: Candidate Regions and Quantitative Traits , 2007, PLoS genetics.

[76]  W. Guan,et al.  Genome-Wide Association Study Identifies Novel Loci Associated With Concentrations of Four Plasma Phospholipid Fatty Acids in the De Novo Lipogenesis Pathway: Results From the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium , 2013, Circulation. Cardiovascular genetics.

[77]  D. Mozaffarian,et al.  Trans-Palmitoleic Acid, Metabolic Risk Factors, and New-Onset Diabetes in U.S. Adults , 2010, Annals of Internal Medicine.

[78]  A. Minihane,et al.  Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]α-linolenic acid to longer-chain fatty acids and partitioning towards β-oxidation in older men , 2003, British Journal of Nutrition.

[79]  B. Browning,et al.  A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. , 2009, American journal of human genetics.

[80]  D. Mozaffarian,et al.  Trans fatty acids and cardiovascular disease. , 2006, The New England journal of medicine.

[81]  R. Mensink,et al.  Compartmental modeling to quantify alpha-linolenic acid conversion after longer term intake of multiple tracer boluses. , 2005, Journal of lipid research.